SK-608-20.1

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSK-608-20.1
Drug Alias NameSK-608-20.1SY-586-170.1
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTubulin agonists
TargetsTubulin
Therapy Area/IndicationsBrain Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTapestry Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTapestry Pharmaceuticals
Active IndicationsN/A
Inactive IndicationsBrain Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A